Day: August 31, 2024
WINNIPEG, Manitoba and WATERLOO, Ontario, Aug. 31, 2024 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (the “Company”) announces that it has closed a non-brokered private placement (the “Offering”) and has issued 8,925,055 units (each, a “Unit”) at a price of $0.055 per Unit for gross proceeds of $490,878. Each “Unit” consists of one common share of the Company, and one common share purchase warrant exercisable at a price of $0.07 until August 29, 2029.
The Offering represents the final tranche of the placement previously announced by the Company on May 28, 2024.
No finders’ fees or commissions were paid in connection with completion of the Offering. All securities issued in connection with the Offering are subject to restrictions on resale until December 30, 2024 in accordance with applicable...
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
SHANGHAI, Aug. 30, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2024 interim financial results and provided corporate updates.
FINANCIAL HIGHLIGHTSAs of June 30, 2024, the total revenue of Junshi Biosciences was approximately RMB786 million during the first half of 2024, representing an increase of approximately 17% compared to 2023. The growth was mainly due to the approximately 11% increase in revenue from pharmaceutical products compared to 2023. In particular, the domestic sales revenue of our core product, TUOYI® (toripalimab), reached approximately RMB671 million, representing an increase of approximately 50%...
Medivolve Announces Management Changes
Written by Customer Service on . Posted in Public Companies.
TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Company”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours.
About Medivolve
Medivolve is a Canadian healthcare technology company headquartered in Toronto, Canada. The Company’s mission is to improve health and lives by delivering world-class diagnostic solutions—starting with COVID-19—as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care...
Victory Square Technologies Reports Q2 2024 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Revenue for the six-months ended June 30, 2024 was $7,993,311, an increase of 46% compared to Q2, 2023
VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that gives investor access to a portfolio of 25+ innovative companies from around the world in a single stock, announces it has filed its Consolidated Financial Statements for the six-months ended June 30th, 2024 along with its Management Discussion and Analysis (MD&A).
Company:
Victory Square is a Venture Builder that provides investors a liquid way to invest in early-stage technology companies without buying a venture fund that requires accredited investor status or multi-year commitments.A diverse portfolio of 25+ innovative companies from around...